Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) reduce appetite and improve metabolic function by activating GLP-1 and GIP receptors in the brain. However, brand-name shortages and insurance denials leave millions seeking accessible options. PlexusDx delivers compounded versions from licensed 503A pharmacies to all 50 states without membership fees or insurance requirements.

How Semaglutide and Tirzepatide Work for Weight Loss

Both medications mimic glucagon-like peptide-1 (GLP-1), a hormone that signals fullness and slows stomach emptying. Semaglutide activates GLP-1 receptors alone, while tirzepatide activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors—a dual-action approach. Clinical trials show tirzepatide produces greater weight loss than semaglutide: up to 22% body weight reduction versus 15-18% over 68 weeks.

These medications also improve insulin sensitivity and reduce cardiovascular risk markers in people with obesity and type 2 diabetes. The appetite-suppressing effects peak within 4-6 weeks as your body adjusts to the peptide signaling. Most patients report sustained weight loss when dose is optimized and combined with structured eating and movement habits.

Compounded vs. Brand-Name GLP-1 Therapy: What's the Difference?

Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are mass-manufactured by pharmaceutical companies under strict FDA oversight. PlexusDx compounded medications contain identical active pharmaceutical ingredients but are prepared in licensed 503A compounding pharmacies that customize strength and delivery form. Both paths provide the same biological effect when dosed correctly.

Compounded options eliminate manufacturer shortages, reduce cost barriers (starting at $149/month for semaglutide), and offer flexibility in dose adjustment without waiting for the next pre-filled pen. PlexusDx handles dosing, supply, and support—your responsibility is consistency with injection schedule or oral timing. Compounded medications are not FDA-approved as brand-name products, but they follow pharmacopeial standards and are dispensed under state pharmacy regulations.

Why Your Genetic Profile Matters in Peptide Therapy

Not everyone responds equally to semaglutide or tirzepatide. Genetic variants in your GLP-1 receptor (GLP1R rs6923761), glucose-dependent insulinotropic polypeptide receptor (GIPR rs1800437), and appetite-control genes (FTO rs9939609, MC4R rs17782313) influence how effectively these peptides suppress hunger and promote weight loss. PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ genetic insights to predict your response profile.

For example, certain GIPR variants predict stronger response to tirzepatide's dual-action mechanism, while GLP1R variants correlate with semaglutide efficacy. The Precision Peptide test costs $99 as an add-on after your first month of treatment—once results arrive, you and your PlexusDx clinician can confirm your current medication is optimal or adjust to better match your genetics. This personalization reduces trial-and-error adjustments and accelerates weight loss outcomes.

PlexusDx Medication Options and Flexible Pricing

PlexusDx offers six compounded formulations: semaglutide injection ($149/month starting), oral semaglutide ($249/month), tirzepatide injection ($249/month starting), oral tirzepatide ($279/month), microdose GLP-1 protocol ($129/month), and dual-compound GLP-Squared injection ($249/month starting). All prices remain flat regardless of your current dose—your dose may need to go up, your price won't. Three commitment tiers provide flexibility without surprise cost increases as you optimize treatment.

All medications are HSA/FSA eligible, require no insurance pre-approval, and ship to your home. PlexusDx serves all 50 states and eliminates membership fees—you pay only for the medication you use. Setup includes a telehealth intake with a clinician who reviews your health history, current weight-loss barriers, and medication preferences to recommend the best starting option.

Starting Your Personalized Weight Loss Journey

Begin by completing a PlexusDx intake form and telehealth consultation to establish your baseline health status, prior medication experiences, and weight-loss timeline. Your clinician will recommend a starting medication and dose based on your metabolic history and clinical profile. Most patients start with semaglutide injection due to its lower entry cost and proven efficacy; others prefer oral formulations for needle-aversion or choose tirzepatide for dual-receptor activation.

After one month of treatment, you're eligible to add the Precision Peptide Genetic Test ($99) to confirm your medication aligns with your genetic predispositions. PlexusDx provides ongoing dose adjustments, side-effect management, and progress tracking without long-term contracts. Consistent injection or oral dosing, combined with mindful eating and regular movement, delivers measurable weight loss within 8-12 weeks for most patients.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as brand-name Ozempic or Wegovy?

Yes. PlexusDx compounded semaglutide contains the identical active pharmaceutical ingredient as Ozempic and Wegovy, prepared in licensed 503A pharmacies. Clinical outcomes depend on dose accuracy and consistency, not brand. Compounded formulations allow faster dose adjustment and lower cost, making weight loss therapy more accessible.

What's the difference between semaglutide and tirzepatide for weight loss?

Semaglutide activates GLP-1 receptors to reduce hunger and slow stomach emptying. Tirzepatide activates both GLP-1 and GIP receptors, producing dual metabolic effects and greater average weight loss (22% vs. 15-18% in trials). Tirzepatide costs slightly more ($249/month vs. $149/month) but may suit patients seeking maximum weight reduction or those with suboptimal response to semaglutide.

How much does PlexusDx weight loss therapy cost per month?

Semaglutide injection starts at $149/month; tirzepatide injection at $249/month; oral formulations range from $249–$279/month. Your dose may increase during treatment, but your monthly price stays flat across three commitment tiers. The Precision Peptide Genetic Test is a $99 add-on after month one. All prices include no insurance requirement and HSA/FSA eligibility.

What are the most common side effects of GLP-1 therapy?

Early side effects include nausea, mild vomiting, and constipation, typically resolving within 1–2 weeks. Tirzepatide may cause nausea slightly more often due to dual-receptor activation. Staying hydrated, eating small frequent meals, and taking over-the-counter anti-nausea remedies reduce discomfort. Serious side effects are rare; your PlexusDx clinician monitors your tolerance at each dose adjustment.

How does the Precision Peptide Genetic Test personalize my weight loss plan?

The test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 other metabolic pathways to predict how strongly you'll respond to semaglutide versus tirzepatide. Results guide clinician recommendations: genetic profiles favoring tirzepatide's dual action receive that medication; those with optimal GLP-1 response continue semaglutide. This reduces medication trial-and-error and accelerates weight loss outcomes.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves